Delivery Order SPE2DR25D2011-SPE2DR26FADHC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,268.40 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical anesthetic medication used for localized pain relief. The order was competitively awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $4,727.04 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The delivery order, which represents a firm fixed-price contract with no set-aside designation, is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical. The award, valued at $24,464.62, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract is scheduled for ultimate completion on September 24, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This competitive, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $6,117.37 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Lidocaine 5% patches (30-count units) with a ceiling value of $2,734.80. This is a firm fixed price, non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $19,570.26 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This firm fixed price contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $3,699.57. This is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract is non-set-aside and was competitively awarded. The place of...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADHCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,256.30 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lidocaine 5% Patch 30S, a topical pain management pharmaceutical. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. The delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that enables supply of a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare systems globally. The company's DLA contract portfolio demonstrates extensive experience delivering medications across multiple therapeutic domains, including pain management, neurological treatments, diabetes care, and specialized medical supplies, positioning it to fulfill the diverse pharmaceutical needs of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/6/25 |